- InvestInvestment SuiteExclusiveFeatures
- PlatformProduct SuiteFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnResourceInvesting GuideEvents
- Partner
- Support
Invest
Platform
Research
Market
Learn
Compare ICICI Prudential Nifty Pharma Index Fund vs Tata India Pharma & Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 0.0 | 4.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 0.93 | 2.13 |
NAV | ₹17.30 | ₹30.71 |
Fund Started | 25 Nov 2022 | 04 Dec 2015 |
Fund Size | ₹74.96 Cr | ₹1208.25 Cr |
Exit Load | - | Exit load of 0.25% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
0.0
4.0
Min SIP Amount
₹1000
₹100
Expense Ratio
0.93
2.13
NAV
₹17.30
₹30.71
Fund Started
25 Nov 2022
04 Dec 2015
Fund Size
₹74.96 Cr
₹1208.25 Cr
Exit Load
-
Exit load of 0.25% if redeemed within 30 days.
Returns
1 Year | 53.41% | 57.04% |
3 Year | - | 21.45% |
5 Year | - | 27.48% |
1 Year
53.41%
57.04%
3 Year
-
21.45%
5 Year
-
27.48%
Holding Analysis
Equity | 99.91% | 93.75% |
Cash | 0.09% | 6.25% |
Equity
99.91%
93.75%
Cash
0.09%
6.25%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 25.51% |
Cipla Ltd. | 11.15% |
Dr. Reddy's Laboratories Ltd. | 10.10% |
Divi's Laboratories Ltd. | 8.47% |
Lupin Ltd. | 6.47% |
Aurobindo Pharma Ltd. | 5.01% |
Alkem Laboratories Ltd. | 3.88% |
Torrent Pharmaceuticals Ltd. | 3.85% |
Zydus Lifesciences Ltd. | 3.28% |
Glenmark Pharmaceuticals Ltd. | 3.09% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.83% |
Aurobindo Pharma Ltd. | 8.96% |
Lupin Ltd. | 7.44% |
Dr. Reddy's Laboratories Ltd. | 6.87% |
Cipla Ltd. | 6.71% |
Divi's Laboratories Ltd. | 4.73% |
Fortis Healthcare Ltd. | 4.35% |
Zydus Lifesciences Ltd. | 4.17% |
Alkem Laboratories Ltd. | 3.77% |
Apollo Hospitals Enterprise Ltd. | 3.51% |
Fund Manager
Name | Kayzad Eghlim | Meeta Shetty |
Start Date | 03 Dec 2021 | 09 Nov 2018 |
Name
Kayzad Eghlim
Meeta Shetty
Start Date
03 Dec 2021
09 Nov 2018
About Fund
Description | The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. |
Launch Date | 25 Nov 2022 | 04 Dec 2015 |
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
25 Nov 2022
04 Dec 2015
